These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16177571)

  • 21. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2.
    Nitta RT; Smith CL; Kennedy BK
    PLoS One; 2007 Sep; 2(9):e963. PubMed ID: 17896003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
    Chen X; Zhang M; Liu LX
    Oncol Rep; 2009 Jul; 22(1):73-80. PubMed ID: 19513507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity.
    Nagao T; Higashitsuji H; Nonoguchi K; Sakurai T; Dawson S; Mayer RJ; Itoh K; Fujita J
    J Biol Chem; 2003 Mar; 278(12):10668-74. PubMed ID: 12525503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor.
    Ando S; Matsuoka T; Kawai K; Sugita S; Joraku A; Kojima T; Suetomi T; Miyazaki J; Fujita J; Nishiyama H
    Int J Urol; 2014 Oct; 21(10):992-8. PubMed ID: 24861729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of MdmX on Mdm2-mediated downregulation of pRB.
    Uchida C; Miwa S; Isobe T; Kitagawa K; Hattori T; Oda T; Yasuda H; Kitagawa M
    FEBS Lett; 2006 Mar; 580(7):1753-8. PubMed ID: 16510145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystallization of gankyrin, an oncoprotein that interacts with CDK4 and the S6b (rpt3) ATPase of the 19S regulator of the 26S proteasome.
    Krzywda S; Brzozowski AM; Al-Safty R; Welchman R; Mee M; Dawson S; Fujita J; Higashitsuji H; Mayer RJ; Wilkinson AJ
    Acta Crystallogr D Biol Crystallogr; 2003 Jul; 59(Pt 7):1294-5. PubMed ID: 12832791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation.
    Wei SJ; Williams JG; Dang H; Darden TA; Betz BL; Humble MM; Chang FM; Trempus CS; Johnson K; Cannon RE; Tennant RW
    J Mol Biol; 2008 Nov; 383(3):693-712. PubMed ID: 18775730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors.
    Blagosklonny MV
    Oncogene; 2001 Jan; 20(3):395-8. PubMed ID: 11313969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
    Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
    Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mdm2 facilitates the association of p53 with the proteasome.
    Kulikov R; Letienne J; Kaur M; Grossman SR; Arts J; Blattner C
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10038-43. PubMed ID: 20479273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of 2,5-substituted pyrimidines as small-molecule gankyrin binders.
    Kanabar D; Kane EI; Chavan T; Laflamme TM; Suarez E; Goyal M; Gupta V; Spratt DE; Muth A
    Future Med Chem; 2024 Feb; 16(3):239-251. PubMed ID: 38205637
    [No Abstract]   [Full Text] [Related]  

  • 33. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest.
    Corcoran CA; Huang Y; Sheikh MS
    Cancer Biol Ther; 2004 Aug; 3(8):721-5. PubMed ID: 15280670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of p53 and MDM2 activity by MTBP.
    Brady M; Vlatkovic N; Boyd MT
    Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma.
    Umemura A; Itoh Y; Itoh K; Yamaguchi K; Nakajima T; Higashitsuji H; Onoue H; Fukumoto M; Okanoue T; Fujita J
    Hepatology; 2008 Feb; 47(2):493-502. PubMed ID: 18161051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDMX exerts its oncogenic activity via suppression of retinoblastoma protein.
    Zhang H; Hu L; Qiu W; Deng T; Zhang Y; Bergholz J; Xiao ZX
    Oncogene; 2015 Oct; 34(44):5560-9. PubMed ID: 25703327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gankyrin regulates cell signaling network.
    Wang X; Jiang B; Zhang Y
    Tumour Biol; 2016 May; 37(5):5675-82. PubMed ID: 26819208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mdm2: a bridge over the two tumour suppressors, p53 and Rb.
    Yap DB; Hsieh JK; Chan FS; Lu X
    Oncogene; 1999 Dec; 18(53):7681-9. PubMed ID: 10618708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.
    Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
    J Cereb Blood Flow Metab; 2005 Feb; 25(2):267-80. PubMed ID: 15678128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16.
    Mahajan A; Guo Y; Yuan C; Weghorst CM; Tsai MD; Li J
    J Mol Biol; 2007 Nov; 373(4):990-1005. PubMed ID: 17881001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.